Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
271.00    0.00 (0.00%)
Bid:
261.00
Ask:
271.00
Spread: 10.00 (3.831%)
Market Cap: £242.70m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Director/PDMR Shareholding

20 Sep 2019 15:05

RNS Number : 1690N
Wilmington PLC
20 September 2019
 

20 September 2019

 

Wilmington plc

Director/PDMR Shareholding

 

 

As announced on 19 September 2019, 64,350 ordinary shares of 5p vested ("Vested Shares") under the Wilmington plc (the "Company") 2007 Performance Share Plan to employees and former employees. Details of Vested Shares to PDMRs are set out below:

 

Individual

Director / PDMR

Number of Vested Shares

Number of Vested Shares sold

Number of Vested Shares Retained

Resultant share holding (Number)

Resultant share holding as a % of the issued share capital with voting rights

Tony Bainbridge

PDMR

6,834

Nil

6,834

6,834

0.01%

 

The Directors, employees and former employees have to pay tax at their marginal income tax rates on the value of the shares awarded to them. Certain employees and former employees elect to sell a number of Vested Shares to pay this tax.

 

Richard Amos

Company Secretary and Chief Financial Officer

 

For further information, please contact:

 

Wilmington plc 020 7422 6800

 

Richard Amos, Company Secretary and Chief Financial Officer

 

FTI Consulting 020 3727 1000

 

Charles Palmer / Dwight Burden / Leah Dudley

 

 

Notes to Editors 

Wilmington is the recognised knowledge leader and partner of choice for information, education and networking in Risk & Compliance, Healthcare and Professional areas. Wilmington employs close to 1,000 people and has customers in 120 countries. Wilmington plc is a premium listed Company on the main market of the London Stock Exchange.

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR") / person closely associated with them ("PCA")

 

a)

Name

Tony Bainbridge

 

2.

Reason for the notification

 

a)

Position /status

Group HR Director

 

b)

Initial notification / amendment

 

Initial Notification

3.

Details of the Issuer

 

a)

Name

Wilmington plc

 

b)

LEI code

 

N/A

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

Identification code

 

Ordinary Shares in Wilmington plc

 

ISIN: GB0009692319

 

b)

Nature of the transaction

Vesting of nil costs awards over 6,834 Ordinary Shares under the Company's 2007 Performance Share Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil Cost

6,834

 

 

d)

Aggregated information

Aggregated volume

Price

 

 

N/A

 

 

e)

Date of the transaction

 

19 September 2019

f)

Place of the transaction

 

London

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLMMITMBMTBTL
Date   Source Headline
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20254:39 pmRNSDirector/PDMR Shareholding
3rd Mar 20254:35 pmRNSDirector/PDMR Shareholding
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSShare repurchase programme
17th Feb 20257:00 amRNSHalf-year Report
17th Jan 20259:42 amRNSNotice of Half Year Results
4th Dec 20247:00 amRNSDirector/PDMR Shareholding
28th Nov 202411:03 amRNSResult of AGM
25th Nov 20241:37 pmRNSHolding(s) in Company
20th Nov 20247:00 amRNSDirector/PDMR Shareholding
8th Nov 20243:13 pmRNSDirector/PDMR Shareholding
1st Nov 20247:00 amRNSTotal Voting Rights
25th Oct 20247:00 amRNSAcquisition of Phoenix Health & Safety
21st Oct 20241:47 pmRNSDirector/PDMR Shareholding
14th Oct 20247:00 amRNSIssue of Ordinary Shares
1st Oct 20247:00 amRNSDirector/PDMR Shareholding
16th Sep 20247:00 amRNSFinancial results for the year ended 30 June 2024
2nd Sep 20247:00 amRNSTotal Voting Rights
29th Jul 20248:59 amRNSDirector Declaration
24th Jul 20247:00 amRNSTrading Statement
10th Jul 202410:57 amRNSHolding(s) in Company
2nd Jul 20242:51 pmRNSTotal Voting Rights - Replacement
1st Jul 20247:00 amRNSTotal Voting Rights
27th Jun 20247:00 amRNSUK Healthcare Business sold for £26.3 million
26th Apr 20247:46 amRNSAPM sold for EUR 26 million
23rd Apr 20243:49 pmRNSSAYE and Director/PDMR Shareholding
19th Feb 20247:00 amRNSHalf-year Report
6th Feb 202411:12 amRNSBoard Changes
1st Feb 20247:00 amRNSMiExact sold for £9.6 million
18th Jan 202411:00 amRNSNotice of Half Year Results
2nd Jan 20247:00 amRNSTotal Voting Rights
18th Dec 20232:42 pmRNSIssue of ordinary shares
11th Dec 20233:54 pmRNSIssue of Ordinary Shares
7th Dec 20232:25 pmRNSIssue of Ordinary Shares
1st Dec 202311:40 amRNSDirector/PDMR Shareholding
30th Nov 20232:53 pmRNSIssue of Ordinary Shares
23rd Nov 20239:49 amRNSAcquisition of Astutis Ltd by Wilmington plc
22nd Nov 20232:37 pmRNSResult of AGM
1st Nov 20237:00 amRNSTotal Voting Rights
3rd Oct 20232:52 pmRNSHolding(s) in Company
2nd Oct 202311:57 amRNSDirector/PDMR Shareholding
2nd Oct 202310:19 amRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSIssue of Ordinary Shares
25th Sep 20236:06 pmRNSAmendment to Financial Results announcement
25th Sep 20237:00 amRNSFinancial results for the year ended 30 June 2023
26th Jul 20237:00 amRNSTrading Statement
11th Apr 20237:00 amRNSSAYE and Director/PDMR Shareholding
7th Mar 20235:32 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.